Medical tests developer to begin trading on US-based venture market
Abingdon Health, a developer, manufacturer and regulatory services provider for diagnostic tests and med-tech, says trading in its ordinary shares will begin next month on the OTCQB Venture Market (OTCQB) in the United States.
By trading on the OTCQB, York-based Abingdon Health shares will be available to trade in US dollars by investors during US working hours.
It says being available on the OTCQB platform has the potential to increase liquidity in its shares on AIM by attracting a... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
